Imunon, Inc. (NASDAQ:IMNN) Q4 2025 Earnings Call Transcript March 31, 2026
Imunon, Inc. beats earnings expectations. Reported EPS is $-1.29, expectations were $-1.43.
Operator: Good morning. My name is Desiree, and I will be your operator today. At this time, I would like to welcome you to Imunon’s Fourth Quarter and Full Year 2025 Financial Results Conference Call. [Operator Instructions] I would now like to turn the call over to Peter Vozzo of ICR Healthcare Investor Relations...
